Hereditary Spastic Paraplegia disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

FSP MCID: HRD010 MIFTS: 66	Hereditary Spastic Paraplegia (FSP) Categories: Bone diseases, Ear diseases, Eye diseases, Gastrointestinal diseases, Genetic diseases, Mental diseases, Metabolic diseases, Nephrological diseases, Neuronal diseases, Rare diseases, Respiratory diseases, Skin diseases
Genes Variations Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs Expand all tables

Sources

Aliases & Classifications for Hereditary Spastic Paraplegia

MalaCards integrated aliases for Hereditary Spastic Paraplegia:

Name: Hereditary Spastic Paraplegia ¹² ⁷⁴ ²⁴ ⁵² ⁵³ ⁵⁸ ³⁶ ²⁹ ⁶ ¹⁵ ³⁷ ³²

Hereditary Spastic Paraparesis ¹² ²⁴ ⁵² ⁵⁸

Familial Spastic Paraplegia ¹² ⁵² ⁵⁸

Strumpell-Lorrain Disease ¹² ⁷⁴ ⁵⁸

Spastic Paraplegia, Hereditary ⁴³ ⁷¹

Hsp ⁵² ⁵⁸

Spg ⁵² ⁵⁸

Spastic Paraplegia 3, Autosomal Dominant ⁷¹

Spastic Paraplegia Hereditary ⁵⁴

Spastic Paraplegia, Familial ⁷⁴

Familial Spastic Paraparesis ⁵²

Strumpell-Lorrain Syndrome ²⁴

French Settlement Disease ¹²

Strümpell-Lorrain Disease ⁵²

Fsp ⁵²

Characteristics:

Orphanet epidemiological data:

⁵⁸

hereditary spastic paraplegia
Inheritance: Autosomal dominant,Autosomal recessive,X-linked recessive; Prevalence: 1-9/100000 (Europe),1-9/100000 (Spain),1-9/100000 (Portugal),1-9/100000 (Worldwide),1-9/100000 (Tunisia),1-9/100000 (Norway),1-9/100000 (Italy),1-9/100000 (Estonia),1-9/100000 (Libyan Arab Jamahiriya); Age of onset: All ages;

Classifications:

MalaCards categories:
Global: Rare diseases Genetic diseases Metabolic diseases
Anatomical: Neuronal diseases Eye diseases Ear diseases Gastrointestinal diseases Skin diseases Respiratory diseases Bone diseases Nephrological diseases Mental diseases

See all MalaCards categories (disease lists)

ICD10: ³² ³³

Diseases of the nervous system

Systemic atrophies primarily affecting the central nervous system

Hereditary ataxia

Hereditary spastic paraplegia

Orphanet: ⁵⁸

Rare neurological diseases

External Ids:

Disease Ontology ¹² DOID:2476

KEGG ³⁶ H00266

ICD9CM ³⁴ 334.1

MeSH ⁴³ D015419

SNOMED-CT ⁶⁷ 39912006 76043009

ICD10 ³² G11.4

ICD10 via Orphanet ³³ G11.4

UMLS via Orphanet ⁷² C0037773 C2931355

Orphanet ⁵⁸ ORPHA685

SNOMED-CT via HPO ⁶⁸ 221360009 22325002 249769001 more

UMLS ⁷¹ C0037773 C2931355

Sources

Summaries for Hereditary Spastic Paraplegia

NINDS : ⁵³ Hereditary spastic paraplegia (HSP), also called familial spastic paraparesis (FSP), refers to a group of inherited disorders that are characterized by progressive weakness and spasticity (stiffness) of the legs. Early in the disease course, there may be mild gait difficulties and stiffness. These symptoms typically slowly progress so that eventually individuals with HSP may require the assistance of a cane, walker, or wheelchair. Though the primary features of "pure" HSP are progressive lower limb spasticity and weakness, complicated forms may be accompanied by other symptoms. These additional symptoms include impaired vision due to cataracts and problems with the optic nerve and retina of the eye, ataxia (lack of muscle coordination), epilepsy, cognitive impairment, peripheral neuropathy, and deafness. The diagnosis of HSP is primarily by neurological examination and testing to rule out other disorders. Brain MRI abnormalities, such as a thin corpus callosum, may be seen in some of the complicated forms of HSP. Several genetic mutations have been identified which underlie various forms of HSP, and specialized genetic testing and diagnosis are available at some medical centers. HSP has several forms of inheritance. Not all children in a family will necessarily develop symptoms, although they may be carriers of the abnormal gene. Symptoms may begin in childhood or adulthood, depending on the particular HSP gene involved.

MalaCards based summary : Hereditary Spastic Paraplegia, also known as hereditary spastic paraparesis, is related to hereditary spastic paraplegia 72 and hereditary spastic paraplegia 23, and has symptoms including urgency of micturition, pain in lower limb and leg cramps. An important gene associated with Hereditary Spastic Paraplegia is SPAST (Spastin), and among its related pathways/superpathways are Endocytosis and Lysosome. The drugs Acetylcholine and Neurotransmitter Agents have been mentioned in the context of this disorder. Affiliated tissues include brain, spinal cord and bone, and related phenotypes are spasticity and gait disturbance

Disease Ontology : ¹² A paraplegia that is characterized by progressive stiffness and contraction (spasticity) in the lower limbs.

NIH Rare Diseases : ⁵² Hereditary spastic paraplegia (HSP) is a group of hereditary, degenerative, neurological disorders that primarily affect the upper motor neurons. Upper motor neurons in the brain and spinal cord deliver signals to the lower motor neurons, which in turn, carry messages to the muscles. In hereditary spastic paraplegia, upper motor neurons slowly degenerate so the muscles do not receive the correct messages, causing progressive spasticity (increased muscle tone/stiffness) and weakness of the legs. This leads to difficulty walking. As degeneration continues, symptoms worsen. If only the lower body is affected, HSP is classified as uncomplicated or pure. HSP is classified as complicated or complex if other systems are involved. In these cases, additional symptoms, including impaired vision, ataxia , epilepsy , cognitive impairment, peripheral neuropathy , and/or deafness, occur. The different forms of HSP are caused by mutations in different genes . Inheritance varies. There are no specific treatments to prevent, slow, or reverse HSP. Individual symptoms may be treated with medications and/or physical therapy .

KEGG : ³⁶ Hereditary spastic paraplegias (SPG) are a group of clinically and genetically diverse disorders characterized by progressive distal limb weakness and lower extremity spasticity.

Wikipedia : ⁷⁴ Hereditary spastic paraplegia (HSP) is a group of inherited diseases whose main feature is a progressive... more...

GeneReviews: NBK1509

Sources

Related Diseases for Hereditary Spastic Paraplegia

Diseases in the Spastic Paraplegia 3a family:

Spastic Paraplegia 3, Autosomal Dominant	Spastic Paraplegia 4, Autosomal Dominant
Spastic Paraplegia 17, Autosomal Dominant	Spastic Paraplegia 15, Autosomal Recessive
Spastic Paraplegia 23, Autosomal Recessive	Spastic Paraplegia 5a, Autosomal Recessive
Spastic Paraplegia 20, Autosomal Recessive	Spastic Paraplegia 6, Autosomal Dominant
Spastic Paraplegia 9a, Autosomal Dominant	Spastic Paraplegia 8, Autosomal Dominant
Spastic Paraplegia 10, Autosomal Dominant	Spastic Paraplegia 11, Autosomal Recessive
Spastic Paraplegia 12, Autosomal Dominant	Spastic Paraplegia 14, Autosomal Recessive
Spastic Paraplegia 13, Autosomal Dominant	Spastic Paraplegia 19, Autosomal Dominant
Spastic Paraplegia 7, Autosomal Recessive	Spastic Paraplegia 24, Autosomal Recessive
Spastic Paraplegia 25, Autosomal Recessive	Spastic Paraplegia 27, Autosomal Recessive
Spastic Paraplegia 26, Autosomal Recessive	Spastic Paraplegia 28, Autosomal Recessive
Spastic Paraplegia 29, Autosomal Dominant	Spastic Paraplegia 33, Autosomal Dominant
Spastic Paraplegia 31, Autosomal Dominant	Spastic Paraplegia 30, Autosomal Recessive
Spastic Paraplegia 18, Autosomal Recessive	Spastic Paraplegia 32, Autosomal Recessive
Spastic Paraplegia 37, Autosomal Dominant	Spastic Paraplegia 39, Autosomal Recessive
Spastic Paraplegia 35, Autosomal Recessive	Spastic Paraplegia 38, Autosomal Dominant
Spastic Paraplegia 42, Autosomal Dominant	Spastic Paraplegia 50, Autosomal Recessive
Spastic Paraplegia 36, Autosomal Dominant	Spastic Paraplegia 45, Autosomal Recessive
Spastic Paraplegia 44, Autosomal Recessive	Spastic Paraplegia 41, Autosomal Dominant
Spastic Paraplegia 48, Autosomal Recessive	Spastic Paraplegia 51, Autosomal Recessive
Spastic Paraplegia 47, Autosomal Recessive	Spastic Paraplegia 52, Autosomal Recessive
Spastic Paraplegia 46, Autosomal Recessive	Spastic Paraplegia 53, Autosomal Recessive
Spastic Paraplegia 56, Autosomal Recessive	Spastic Paraplegia 49, Autosomal Recessive
Spastic Paraplegia 54, Autosomal Recessive	Spastic Paraplegia 55, Autosomal Recessive
Spastic Paraplegia 43, Autosomal Recessive	Spastic Paraplegia 79, Autosomal Recessive
Spastic Paraplegia 72, Autosomal Recessive	Spastic Paraplegia 57, Autosomal Recessive
Spastic Paraplegia 62, Autosomal Recessive	Spastic Paraplegia 64, Autosomal Recessive
Spastic Paraplegia 61, Autosomal Recessive	Spastic Paraplegia 63, Autosomal Recessive
Spastic Paraplegia 73, Autosomal Dominant	Spastic Paraplegia 74, Autosomal Recessive
Spastic Paraplegia 9b, Autosomal Recessive	Spastic Paraplegia 75, Autosomal Recessive
Spastic Paraplegia 76, Autosomal Recessive	Spastic Paraplegia 77, Autosomal Recessive
Spastic Paraplegia 78, Autosomal Recessive	Spastic Paraplegia 80, Autosomal Dominant
Hereditary Spastic Paraplegia 23	Hereditary Spastic Paraplegia 51
Hereditary Spastic Paraplegia 72	Hereditary Spastic Paraplegia
Spastic Paraplegia 4	Spastic Paraplegia 8
Spastic Paraplegia 11	Spastic Paraplegia 10
Spastic Paraplegia 12	Spastic Paraplegia 13
Spastic Paraplegia 14	Spastic Paraplegia 15
Spastic Paraplegia 16	Spastic Paraplegia 17
Spastic Paraplegia 18	Spastic Paraplegia 19
Spastic Paraplegia 24	Spastic Paraplegia 25
Spastic Paraplegia 26	Spastic Paraplegia 29
Spastic Paraplegia 3	Spastic Paraplegia 32
Spastic Paraplegia 39	Spastic Paraplegia 47
Spastic Paraplegia 5a	Spastic Paraplegia 5b
Spastic Paraplegia 6	Spastic Paraplegia 9
Spastic Paraplegia Type 49	Autosomal Recessive Spastic Paraplegia Type 60
Autosomal Recessive Spastic Paraplegia Type 59	Autosomal Recessive Spastic Paraplegia Type 69
Autosomal Recessive Spastic Paraplegia Type 70	Autosomal Recessive Spastic Paraplegia Type 71
Autosomal Recessive Spastic Paraplegia Type 66	Autosomal Recessive Spastic Paraplegia Type 67
Autosomal Dominant Spastic Paraplegia Type 9b

Diseases related to Hereditary Spastic Paraplegia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 717)

#	Related Disease	Score	Top Affiliating Genes
1	hereditary spastic paraplegia 72	35.8	ZFYVE26 SPG11 SPAST REEP1 NIPA1 ATL1
2	hereditary spastic paraplegia 23	35.7	ZFYVE26 WASHC5 SPG11 SPART CYP7B1
3	spastic paraplegia 4, autosomal dominant	35.6	ZFYVE27 ZFYVE26 WASHC5 SPG7 SPG11 SPAST
4	spastic paraplegia 31, autosomal dominant	35.6	ZFYVE27 ZFYVE26 WASHC5 SPG7 SPG11 SPAST
5	spastic paraplegia 2, x-linked	35.6	ZFYVE27 ZFYVE26 WASHC5 SPG7 SPG11 SPAST
6	masa syndrome	35.6	ZFYVE27 ZFYVE26 WASHC5 SPG7 SPG11 SPAST
7	spastic paraplegia 20, autosomal recessive	35.5	ZFYVE26 SPG7 SPG11 SPAST SPART NIPA1
8	hereditary spastic paraplegia 51	35.5	ZFYVE26 SPG11 NIPA1 AP5Z1
9	spastic paraplegia 15, autosomal recessive	35.4	ZFYVE27 ZFYVE26 WASHC5 SPG7 SPG11 SPAST
10	spastic paraplegia 17, autosomal dominant	35.4	ZFYVE26 WASHC5 SPG11 SPAST SPART REEP1
11	pure hereditary spastic paraplegia	35.4	SPAST NIPA1 KIF5A ATL1
12	complex hereditary spastic paraplegia	35.4	SPG7 SPG11 NIPA1 CYP7B1
13	spastic paraplegia 10, autosomal dominant	35.4	ZFYVE27 ZFYVE26 WASHC5 SPG7 SPG11 SPAST
14	spastic paraplegia 6, autosomal dominant	35.3	ZFYVE27 ZFYVE26 WASHC5 SPG11 SPAST SPART
15	spastic paraplegia 8, autosomal dominant	35.3	ZFYVE27 ZFYVE26 WASHC5 SPG11 SPAST SPART
16	spastic paraplegia 3, autosomal dominant	35.3	ZFYVE26 WASHC5 SPG11 SPAST REEP1 NIPA1
17	spastic paraplegia 42, autosomal dominant	35.3	ZFYVE27 ZFYVE26 WASHC5 SPG11 SPAST SPART
18	spastic paraplegia 30, autosomal recessive	35.2	WASHC5 SPG11 SPAST REEP1 NIPA1 KIF5A
19	spastic paraplegia 12, autosomal dominant	35.2	ZFYVE27 ZFYVE26 WASHC5 SPG11 SPAST REEP1
20	spastic paraplegia 18, autosomal recessive	35.2	ZFYVE26 WASHC5 SPG7 SPG11 REEP1 NIPA1
21	spastic paraplegia 5a, autosomal recessive	35.2	ZFYVE26 SPG7 SPG11 SPAST KIF5A CYP7B1
22	spastic paraplegia 13, autosomal dominant	35.2	SPG7 SPAST REEP1 NIPA1 KIF5A HSPD1
23	spastic paraplegia 39, autosomal recessive	35.2	ZFYVE26 WASHC5 SPG11 SPAST SPART GBA2
24	spastic paraplegia 48, autosomal recessive	35.2	ZFYVE26 WASHC5 SPG11 SPAST REEP1 ATL1
25	spastic paraplegia 35, autosomal recessive	35.1	ZFYVE26 WASHC5 SPG7 SPG11 REEP1 C19orf12
26	spastic paraplegia 26, autosomal recessive	35.1	ZFYVE26 WASHC5 SPG11 SPAST SPART REEP1
27	spastic paraplegia 43, autosomal recessive	35.1	ZFYVE27 ZFYVE26 SPG11 SPAST GBA2 C19orf12
28	spastic paraplegia 11, autosomal recessive	35.0	ZFYVE26 SPG7 SPG11
29	spastic paraplegia 54, autosomal recessive	35.0	SPG7 SPG11 REEP1 GBA2 AP5Z1
30	spastic paraplegia 46, autosomal recessive	35.0	ZFYVE26 SPG7 SPG11 GBA2 AP5Z1
31	spastic paraplegia 57, autosomal recessive	35.0	SPG11 REEP1 KIF5A KIF1A ALS2
32	spastic paraplegia 14, autosomal recessive	35.0	ZFYVE26 WASHC5 SPG11 SPAST
33	spastic paraplegia 16, x-linked	35.0	ZFYVE26 WASHC5 SPG11 SPAST
34	spastic paraplegia 28, autosomal recessive	35.0	SPG7 SPG11 REEP1 CYP7B1
35	spastic paraplegia 33, autosomal dominant	34.9	ZFYVE27 WASHC5 SPAST SPART REEP1 NIPA1
36	spastic paraplegia 77, autosomal recessive	34.9	ZFYVE26 SPG11 GBA2 CYP7B1
37	spastic paraplegia 44, autosomal recessive	34.9	ZFYVE27 ZFYVE26 WASHC5 AP5Z1
38	spastic paraplegia 7, autosomal recessive	34.9	SPG7 AFG3L2
39	spastic paraplegia 32, autosomal recessive	34.9	ZFYVE26 SPG7 SPG11
40	spastic paraplegia 61, autosomal recessive	34.9	SPAST REEP1 ATL1
41	spastic paraplegia 56, autosomal recessive	34.9	SPG11 GBA2 AP5Z1
42	spastic paraplegia 64, autosomal recessive	34.9	SPG7 SPG11 ALS2
43	mast syndrome	34.8	ZFYVE27 SPG11 SPART
44	spastic paraplegia 47, autosomal recessive	34.8	ZFYVE26 WASHC5 SPG11 REEP1 AP5Z1
45	spastic paraplegia 50, autosomal recessive	34.8	ZFYVE26 WASHC5 SPG11 NIPA1 AP5Z1
46	spastic paraplegia 34, x-linked	34.8	ZFYVE26 WASHC5
47	spastic paraplegia 29, autosomal dominant	34.8	ZFYVE26 WASHC5
48	spastic paraplegia 37, autosomal dominant	34.8	ZFYVE26 WASHC5
49	spastic paraplegia 19, autosomal dominant	34.7	ZFYVE26 WASHC5
50	spastic paraplegia 25, autosomal recessive	34.7	ZFYVE26 WASHC5

Graphical network of the top 20 diseases related to Hereditary Spastic Paraplegia:

Sources

Symptoms & Phenotypes for Hereditary Spastic Paraplegia

Human phenotypes related to Hereditary Spastic Paraplegia:

⁵⁸ ³¹ (show all 6)

#	Description	HPO Frequency	Orphanet Frequency	HPO Source Accession
1	spasticity ⁵⁸ ³¹	hallmark (90%)	Very frequent (99-80%)	HP:0001257
2	gait disturbance ⁵⁸ ³¹	hallmark (90%)	Very frequent (99-80%)	HP:0001288
3	impaired pain sensation ⁵⁸ ³¹	hallmark (90%)	Very frequent (99-80%)	HP:0007328
4	paraplegia ⁵⁸ ³¹	hallmark (90%)	Very frequent (99-80%)	HP:0010550
5	ataxia ⁵⁸ ³¹	frequent (33%)	Frequent (79-30%)	HP:0001251
6	finger syndactyly ⁵⁸ ³¹	occasional (7.5%)	Occasional (29-5%)	HP:0006101

UMLS symptoms related to Hereditary Spastic Paraplegia:

urgency of micturition, pain in lower limb, leg cramps

MGI Mouse Phenotypes related to Hereditary Spastic Paraplegia:

⁴⁵

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	behavior/neurological	MP:0005386	9.77	AFG3L2 ALS2 ATL1 HSPD1 KIF1A KIF5A
2	nervous system	MP:0003631	9.4	AFG3L2 ALS2 HSPD1 KIF1A KIF5A KY

Sources

Drugs & Therapeutics for Hereditary Spastic Paraplegia

Drugs for Hereditary Spastic Paraplegia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 33)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Acetylcholine

Approved, Investigational

Phase 2, Phase 3

51-84-3

187

Synonyms:

2-(Acetyloxy)-N,N,N-trimethylethanaminium

Acetilcolina cusi

Acetyl choline ion

Acetylcholine bromide

Acetylcholine cation

acetylcholine chloride

Acetylcholine chloride

Acetylcholine fluoride

Acetylcholine hydroxide

Acetylcholine iodide

Acetylcholine L tartrate

Acetylcholine L-tartrate

Acetylcholine perchlorate

Acetylcholine picrate

Acetylcholine picrate (1:1)

Acetylcholine sulfate (1:1)

Acetylcholinium: acetyl-choline

ACh

Alcon brand OF acetylcholine chloride

Azetylcholin

Bournonville brand OF acetylcholine chloride

Bromide, acetylcholine

Bromoacetylcholine

Chloroacetylcholine

Choline acetate

Choline acetate (ester)

Choline acetic acid

Ciba vision brand OF acetylcholine chloride

Cusi, acetilcolina

Fluoride, acetylcholine

Hydroxide, acetylcholine

Iodide, acetylcholine

Iolab brand OF acetylcholine chloride

L-Tartrate, acetylcholine

Miochol

O-Acetylcholine

Perchlorate, acetylcholine

Neurotransmitter Agents

Phase 2, Phase 3

Acetylcholine Release Inhibitors

Phase 2, Phase 3

Botulinum Toxins

Phase 2, Phase 3

Cholinergic Agents

Phase 2, Phase 3

Atorvastatin

Approved

Phase 2

134523-00-5

60823

Synonyms:

(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid

(3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid

(betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid

(R-(R*,r*))-2-(4-fluorophenyl)-b,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate

(R-(R*,r*))-2-(4-fluorophenyl)-b,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid

(R-(R*,r*))-2-(4-fluorophenyl)-b,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate

(R-(R*,r*))-2-(4-fluorophenyl)-b,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid

(R-(R*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate

(R-(R*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid

(R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid

(R-(R*,r*))-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate

(R-(R*,r*))-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid

134523-00-5

134523-03-8

7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]- 3,5-DIHYDROXY-HEPTANOIC ACID

7-[2-(4-fluoro-PHENYL)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-3,5-dihydroxy-heptanoate

7-[2-(4-fluoro-PHENYL)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-3,5-dihydroxy-heptanoIC ACID

AC-15611

AC1L1TZT

AC1Q1OZQ

AKOS000281127

Anhydrous, atorvastatin calcium

Atogal

Atorlip

Atorpic

atorvastatin

Atorvastatin

Atorvastatin (INN)

Atorvastatin [INN:BAN]

Atorvastatin acid

Atorvastatin calcium

Atorvastatin calcium anhydrous

Atorvastatin calcium hydrate

Atorvastatin calcium trihydrate

Atorvastatin, calcium salt

atorvastatina

Atorvastatina

atorvastatine

Atorvastatine

atorvastatinium

atorvastatinum

Atorvastatinum

atrovastin

BIDD:GT0336

C06834

C33H35FN2O5

Calcium anhydrous, atorvastatin

Calcium hydrate, atorvastatin

Calcium salt atorvastatin

Calcium trihydrate, atorvastatin

Calcium, atorvastatin

Cardyl

CCRIS 7159

CHEBI:39548

CHEMBL1487

CI 981

CID60823

D07474

DB01076

Faboxim

Hipolixan

HSDB 7039

Hydrate, atorvastatin calcium

Lipitor

Lipitor (TN)

Lipitor(TM)

Lipotropic

Lipovastatinklonal

Liprimar

Liptonorm

Lowden

LS-136975

MolPort-000-883-773

NCGC00159458-02

nchembio.301-comp8

Normalip

Sincol

Sortis

Sortis (TN)

Sotis

Torvacard

Torvast

Totalip

Tozalip

Trihydrate, atorvastatin calcium

Tulip

UNII-A0JWA85V8F

Vastina

Xanator

Xarator

Xavator

Zurinel

Resveratrol

Approved, Experimental, Investigational

Phase 2

501-36-0

445154

Synonyms:

(e)-5-(2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol

(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol

(e)-Resveratrol

(E)-resveratrol

3,4',5-Stilbenetriol

3,4',5-trihydroxystilbene

3,4',5-Trihydroxystilbene

3,4',5-trihydroxy-trans-stilbene

3,4',5-Trihydroxy-trans-stilbene

3,5,4'-trihydroxystilbene

3,5,4'-Trihydroxystilbene

5-[(e)-2-(4-Hydroxyphenyl)vinyl]benzene-1,3-diol

5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol

cis-Resveratrol

Resveratrol-3-sulfate

SRT 501

SRT-501

trans-3,4',5 - Trihydroxystilbene

trans-resveratrol

trans-Resveratrol

chenodeoxycholic acid

Approved

Phase 2

474-25-9

10133

Synonyms:

(+)-Chenodeoxycholate

(+)-Chenodeoxycholic acid

(3a,5b,7a)-3,7-Dihydroxy-cholan-24-Oate

(3a,5b,7a)-3,7-Dihydroxy-cholan-24-Oic acid

3a,7a-Dihydroxy-5b,14a,17b-cholanate

3a,7a-Dihydroxy-5b,14a,17b-cholanic acid

3a,7a-Dihydroxy-5b-cholan-24-Oate

3a,7a-Dihydroxy-5b-cholan-24-Oic acid

3a,7a-Dihydroxy-5b-cholanate

3a,7a-Dihydroxy-5b-cholanic acid

3alpha,7alpha-Dihydroxy-5beta-cholanate

3alpha,7alpha-Dihydroxy-5beta-cholanic acid

3α,7α-dihydroxy-5β-cholanate

3α,7α-dihydroxy-5β-cholanic acid

7a-Hydroxy-desoxycholsaeure

7a-Hydroxylithocholate

7a-Hydroxylithocholic acid

7alpha-Hydroxylithocholate

7alpha-Hydroxylithocholic acid

7α-hydroxylithocholate

7α-hydroxylithocholic acid

Acid, chenic

Acid, chenique

Acid, chenodeoxycholic

Acid, gallodesoxycholic

Acide chenodeoxycholique

Acido chenodeoxicholico

Acidum chenodeoxycholicum

Anthropodeoxycholate

Anthropodeoxycholic acid

Anthropodesoxycholate

Anthropodesoxycholic acid

Antigen brand OF chenodeoxycholic acid

CDCA

Chenate

Chenic acid

Chenique acid

Chenix

Chenocholic acid

Chenodeoxycholate

Chenodeoxycholate, sodium

Chenodeoxycholic acid

Chenodesoxycholic acid

Chenodesoxycholsaeure

Chenodiol

Chenofalk

Chenophalk

Estedi brand OF chenodeoxycholic acid

Falk brand OF chenodeoxycholic acid

Gallodesoxycholate

Gallodesoxycholic acid

Henohol

Quenobilan

Quenocol

Sodium chenodeoxycholate

Solvay brand OF chenodeoxycholic acid

tramedico Brand OF chenodeoxycholic acid

Zambon brand OF chenodeoxycholic acid

Evolocumab

Approved

Phase 1, Phase 2

1256937-27-5

Cathartics

Phase 2

Anti-Inflammatory Agents

Phase 2

Gastrointestinal Agents

Phase 2

Anti-Inflammatory Agents, Non-Steroidal

Phase 2

Antioxidants

Phase 2

Platelet Aggregation Inhibitors

Phase 2

Analgesics, Non-Narcotic

Phase 2

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Phase 2

Laxatives

Phase 2

Antirheumatic Agents

Phase 2

Protective Agents

Phase 2

Analgesics

Phase 2

Hypolipidemic Agents

Phase 1, Phase 2

Anticholesteremic Agents

Phase 1, Phase 2

Lipid Regulating Agents

Phase 1, Phase 2

Antimetabolites

Phase 1, Phase 2

Antibodies, Monoclonal

Phase 1, Phase 2

Antibodies

Phase 1, Phase 2

Immunoglobulins

Phase 1, Phase 2

Immunologic Factors

Phase 1, Phase 2

Creatine

Approved, Investigational, Nutraceutical

57-00-1

586

Synonyms:

((amino(imino)Methyl)(methyl)amino)acetate

((amino(imino)Methyl)(methyl)amino)acetic acid

((amino(Imino)methyl)(methyl)amino)acetic acid

(alpha-methylguanido)Acetate

(alpha-methylguanido)Acetic acid

(alpha-Methylguanido)acetic acid

(a-methylguanido)Acetate

(a-methylguanido)Acetic acid

(N-methylcarbamimidamido)Acetate

(N-methylcarbamimidamido)acetic acid

(N-methylcarbamimidamido)Acetic acid

(α-methylguanido)acetate

(α-methylguanido)acetic acid

[[amino(imino)Methyl](methyl)amino]acetate

[[amino(imino)Methyl](methyl)amino]acetic acid

alpha-methylguanidino Acetate

alpha-methylguanidino Acetic acid

alpha-Methylguanidino acetic acid

a-methylguanidino Acetate

a-methylguanidino Acetic acid

Cosmocair C 100

Creatin

Creatine

Creatine hydrate

Kreatin

Krebiozon

Methylglycocyamine

Methylguanidoacetate

Methylguanidoacetic acid

N-(aminoiminomethyl)-N-methylglycine

N-(Aminoiminomethyl)-N-methylglycine

N-(Aminoiminomethyl)-N-methyl-glycine

N-[(e)-amino(imino)METHYL]-N-methylglycine

N-amidinosarcosine

N-Amidinosarcosine

N-carbamimidoyl-N-methylglycine

N-Carbamimidoyl-N-methylglycine

N-methyl-N-guanylglycine

N-Methyl-N-guanylglycine

Phosphagen

α-methylguanidino acetate

α-methylguanidino acetic acid

Aspartic acid

Approved, Nutraceutical

56-84-8

5960

Synonyms:

(+)-Aspartate

(+)-Aspartic acid

(+-)-Aspartic acid

(2S)-Aspartate

(2S)-Aspartic acid

(L)-Aspartate

(L)-Aspartic acid

(R)-2-Aminosuccinate

(R,S)-Aspartic acid

(S)-(+)-Aspartate

(S)-(+)-Aspartic acid

(S)-2-Aminobutanedioate

(S)-2-aminobutanedioic acid

(S)-2-Aminobutanedioic acid

(S)-2-Aminosuccinate

(S)-2-aminosuccinic acid

(S)-2-Aminosuccinic acid

(S)-amino-Butanedioate

(S)-Aminobutanedioate

(S)-amino-Butanedioic acid

(S)-Aminobutanedioic acid

(S)-Aspartate

(S)-Aspartic acid

2-amino-3-Methylsuccinate

2-amino-3-Methylsuccinic acid

2-Aminosuccinate

2-Aminosuccinic acid

ácido aspártico

Acidum asparticum

alpha-Aminosuccinate

alpha-Aminosuccinic acid

Aminosuccinate

Ammonium aspartate

Asp

Asparagate

Asparagic acid

Asparaginate

Asparaginic acid

Asparatate

ASPARTate

Aspartate magnesium hydrochloride

Aspartate, ammonium

Aspartate, calcium

Aspartate, dipotassium

Aspartate, disodium

Aspartate, magnesium

Aspartate, monopotassium

Aspartate, monosodium

Aspartate, potassium

Aspartate, sodium

Aspartic acid

ASPARTIC ACID

Aspartic acid, ammonium salt

Aspartic acid, calcium salt

Aspartic acid, dipotassium salt

Aspartic acid, disodium salt

Aspartic acid, hydrobromide

Aspartic acid, hydrochloride

Aspartic acid, magnesium (1:1) salt, hydrochloride, trihydrate

Aspartic acid, magnesium (2:1) salt

Aspartic acid, magnesium-potassium (2:1:2) salt

Aspartic acid, monopotassium salt

Aspartic acid, monosodium salt

Aspartic acid, potassium salt

Aspartic acid, sodium salt

Calcium aspartate

Dipotassium aspartate

Disodium aspartate

H-Asp-OH

Hydrobromide aspartic acid

Hydrochloride aspartic acid

Hydrochloride, aspartate magnesium

L Aspartate

L Aspartic acid

L-(+)-Aspartate

L-(+)-Aspartic acid

L-Aminosuccinate

L-Aminosuccinic acid

L-Asp

L-Asparagate

L-Asparagic acid

L-Asparaginate

L-Asparaginic acid

L-Asparaginsaeure

L-Asparaginsäure

L-Aspartate

L-Aspartic acid

Magnesiocard

Magnesium aspartate

MG 5 Longoral

MG5Longoral

MG-5-Longoral

Monopotassium aspartate

Monosodium aspartate

Poly-DL-succinimide

Polysuccinimide

Potassium aspartate

Sodium aspartate

Choline

Approved, Nutraceutical

62-49-7

305

Synonyms:

(2-Hydroxyethyl)trimethyl ammonium

(2-Hydroxyethyl)trimethylammonium

(beta-Hydroxyethyl)trimethylammonium

2-Hydroxy-N,N,N-trimethylethanaminium

2-Hydroxy-N,N,N-trimethyl-ethanaminium

Bilineurine

Biocolina

Biocoline

Bitartrate, choline

Bursine

Chloride, choline

Choline bitartrate

Choline cation

Choline chloride

Choline citrate

Choline hydroxide

Choline ion

CHOLINE ion

Choline O sulfate

Choline O-sulfate

Cholinum

Citrate, choline

Fagine

Hepacholine

Hormocline

Hydroxide, choline

Lipotril

N,N,N-trimethylethanol-ammonium

N,N,N-Trimethylethanolammonium

N,N,N-Trimethylethanol-ammonium

Neocolina

N-trimethylethanolamine

N-Trimethylethanolamine

O-Sulfate, choline

Paresan

trimethylethanolamine

Trimethylethanolamine

Vidine

Vitamin J

N-Methylaspartate

Interventional clinical trials:

(show all 16)

#	Name	Status	NCT ID	Phase	Drugs
1	Botulinum Toxin in Patients With Hereditary Spastic Paraplegia: a Randomized, Double-blind, Placebo-controlled, Crossover Study	Completed	NCT02604186	Phase 2, Phase 3
2	Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5	Completed	NCT02314208	Phase 2	Xenbilox;Tahor
3	Design and Validation of a Modular Physiotherapy Concept for the Treatment of Hereditary Spastic Spinal Paralysis (HSP) - a Randomized Study	Completed	NCT03961906	Phase 2
4	PCSK9 Inhibitor Treatment for Patients With Hereditary Spastic Paraplegia Type 5	Recruiting	NCT04101643	Phase 1, Phase 2	evolocumab
5	Nuclear Magnetic Spectroscopy for the Evaluation of Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis	Completed	NCT00023075
6	A Pilot Study of Repetitive Transcranial Magnetic Stimulation for Improvement of Gait in Hereditary Spastic Paraplegia and Adrenomyeloneuropathy	Completed	NCT03627416
7	A Patient Centric Motor Neuron Disease Activities of Daily Living Scale	Completed	NCT02852278
8	Studying Cognition in SPG4 Compared to Healthy Controls	Completed	NCT03104088
9	Improving Gait Adaptability in Hereditary Spastic Paraplegia During Task-specific Training on the C-Mill: Towards Evidence-Based and Individually Tailored Rehabilitation	Recruiting	NCT04180098
10	Disease Natural History and Biomarkers of SPG3A, SPG4 and SPG31	Recruiting	NCT02859428
11	Studying the Presymptomatic and Early Phase of SPG4	Recruiting	NCT03206190
12	Phenotype, Genotype & Biomarkers in ALS and Related Disorders	Recruiting	NCT02327845
13	Clinical and Molecular Manifestations of Neuromuscular and Neurogenetic Disorders of Childhood	Recruiting	NCT01568658
14	Studying Non-motor Symptoms in Patients With Hereditary Spastic Paraplegia (HSP) Compared to Healthy Controls	Recruiting	NCT03204773
15	Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorders	Not yet recruiting	NCT03981276
16	Investigating the Role of SPG20,STK31 Genes in the Carcinogenesis of Colorectal Cancer	Not yet recruiting	NCT03261752

Search NIH Clinical Center for Hereditary Spastic Paraplegia

Cochrane evidence based reviews: spastic paraplegia, hereditary

Sources

Genetic Tests for Hereditary Spastic Paraplegia

Genetic tests related to Hereditary Spastic Paraplegia:

#	Genetic test	Affiliating Genes
1	Hereditary Spastic Paraplegia ²⁹

Sources

Anatomical Context for Hereditary Spastic Paraplegia

MalaCards organs/tissues related to Hereditary Spastic Paraplegia:

⁴⁰

Brain, Spinal Cord, Bone, Eye, Testes, Retina, Kidney

Sources

Publications for Hereditary Spastic Paraplegia

Articles related to Hereditary Spastic Paraplegia:

(show top 50) (show all 1556)

#	Title	Authors	PMID	Year
1	A clinical, genetic, and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia. ⁵⁴ ⁶¹ ²⁴	Arnoldi A...Bassi MT	18200586	2008
2	Mutation in KIF5A can also cause adult-onset hereditary spastic paraplegia. ⁵⁴ ⁶¹ ²⁴	Blair MA...Hedera P	16489470	2006
3	De novo occurrence of novel SPG3A/atlastin mutation presenting as cerebral palsy. ⁵⁴ ⁶¹ ²⁴	Rainier S...Fink JK	16533974	2006
4	Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation. ⁵⁴ ⁶¹ ²⁴	Nielsen JE...Sorensen SA	15667412	2004
5	SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia. ⁵⁴ ⁶¹ ²⁴	Patel H...Crosby AH	12134148	2002
6	A novel heterozygous variant in ERLIN2 causes autosomal dominant pure hereditary spastic paraplegia. ⁶¹ ²⁴	Rydning SL...Kamm C	29528531	2018
7	Novel homozygous GBA2 mutation in a patient with complicated spastic paraplegia. ⁶¹ ²⁴	Coarelli G...Ristori G	29524657	2018
8	ERLIN1 mutations cause teenage-onset slowly progressive ALS in a large Turkish pedigree. ⁶¹ ²⁴	Tunca C...Basak AN	29453415	2018
9	ATPase-deficient mitochondrial inner membrane protein ATAD3A disturbs mitochondrial dynamics in dominant hereditary spastic paraplegia. ⁶¹ ²⁴	Cooper HM...Tyynismaa H	28158749	2017
10	NT5C2 novel splicing variant expands the phenotypic spectrum of Spastic Paraplegia (SPG45): case report of a new member of thin corpus callosum SPG-Subgroup. ⁶¹ ²⁴	Elsaid MF...Abdel Aleem A	28327087	2017
11	ALS and MMN mimics in patients with BSCL2 mutations: the expanding clinical spectrum of SPG17 hereditary spastic paraplegia. ⁶¹ ²⁴	Musacchio T...Klebe S	27738760	2017
12	Mutational analysis of the CYP7B1, PNPLA6 and C19orf12 genes in autosomal recessive hereditary spastic paraplegia. ⁶¹ ²⁴	Schubert SF...Dekomien G	26714052	2016
13	Hereditary and metabolic myelopathies. ⁶¹ ²⁴	Hedera P	27430441	2016
14	Hereditary spastic paraplegia with recessive trait caused by mutation in KLC4 gene. ⁶¹ ²⁴	Bayrakli F...Ziyal I	26423925	2015
15	Adult-onset autosomal dominant spastic paraplegia linked to a GTPase-effector domain mutation of dynamin 2. ⁶¹ ²⁴	Sambuughin N...Toro C	26517984	2015
16	Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia. ⁶¹ ²⁴	Coutelier M...Stevanin G	26026163	2015
17	Mosaic dominant TUBB4A mutation in an inbred family with complicated hereditary spastic paraplegia. ⁶¹ ²⁴	Kancheva D...Jordanova A	25772097	2015
18	Fe/S protein assembly gene IBA57 mutation causes hereditary spastic paraplegia. ⁶¹ ²⁴	Lossos A...Lill R	25609768	2015
19	Mutations in ADAR1, IFIH1, and RNASEH2B presenting as spastic paraplegia. ⁶¹ ²⁴	Crow YJ...Rice GI	25243380	2014
20	A complex form of hereditary spastic paraplegia in three siblings due to somatic mosaicism for a novel SPAST mutation in the mother. ⁶¹ ²⁴	Aulitzky A...Volk AE	25315759	2014
21	Extended phenotypic spectrum of KIF5A mutations: From spastic paraplegia to axonal neuropathy. ⁶¹ ²⁴	Liu YT...Houlden H	25008398	2014
22	Motor protein mutations cause a new form of hereditary spastic paraplegia. ⁶¹ ²⁴	Caballero Oteyza A...Schule R	24808017	2014
23	Molecular epidemiology and clinical spectrum of hereditary spastic paraplegia in the Japanese population based on comprehensive mutational analyses. ⁶¹ ²⁴	Ishiura H...Tsuji S	24451228	2014
24	KIF1C mutations in two families with hereditary spastic paraparesis and cerebellar dysfunction. ⁶¹ ²⁴	Dor T...Edvardson S	24319291	2014
25	Loss of association of REEP2 with membranes leads to hereditary spastic paraplegia. ⁶¹ ²⁴	Esteves T...Darios F	24388663	2014
26	PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum. ⁶¹ ²⁴	Synofzik M...Zuchner S	24355708	2014
27	Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis. ⁶¹ ²⁴	Harlalka GV...Crosby AH	24103911	2013
28	Recurrent de novo c.316G>A mutation in NIPA1 hotspot. ⁶¹ ²⁴	Hedera P	24075313	2013
29	Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12. ⁶¹ ²⁴	Landoure G...Burnett BG	23857908	2013
30	Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia. ⁶¹ ²⁴	Boukhris A...Stevanin G	23746551	2013
31	Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia. ⁶¹ ²⁴	Oates EC...Reilly MM	23664120	2013
32	Mutation in TECPR2 reveals a role for autophagy in hereditary spastic paraparesis. ⁶¹ ²⁴	Oz-Levi D...Lancet D	23176824	2012
33	Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia. ⁶¹ ²⁴	Tesson C...Stevanin G	23176821	2012
34	Mutations in DDHD2, encoding an intracellular phospholipase A(1), cause a recessive form of complex hereditary spastic paraplegia. ⁶¹ ²⁴	Schuurs-Hoeijmakers JH...de Brouwer AP	23176823	2012
35	Mutation in the AP4B1 gene cause hereditary spastic paraplegia type 47 (SPG47) . ⁶¹ ²⁴	Bauer P...Schols L	22290197	2012
36	Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12. ⁶¹ ²⁴	Montenegro G...Zuchner S	22232211	2012
37	A nullimorphic ERLIN2 mutation defines a complicated hereditary spastic paraplegia locus (SPG18). ⁶¹ ²⁴	Alazami AM...Alkuraya FS	21796390	2011
38	NIPA1 mutation in complex hereditary spastic paraplegia with epilepsy. ⁶¹ ²⁴	Svenstrup K...Nielsen JE	21599812	2011
39	Expansion of the phenotypic spectrum of SPG6 caused by mutation in NIPA1. ⁶¹ ²⁴	Du J...Shen L	21419568	2011
40	Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early-onset levodopa-responsive Parkinsonism. ⁶¹ ²⁴	Guidubaldi A...Bentivoglio AR	21381113	2011
41	Hereditary spastic paraplegia-like disorder due to a mitochondrial ATP6 gene point mutation. ⁶¹ ²⁴	Verny C...Procaccio V	20656066	2011
42	A genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic paraplegia. ⁶¹ ²⁴	Slabicki M...Buchholz F	20613862	2010
43	Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35). ⁶¹ ²⁴	Dick KJ...Crosby AH	20104589	2010
44	Dementia in SPG4 hereditary spastic paraplegia: clinical, genetic, and neuropathologic evidence. ⁶¹ ²⁴	Murphy S...Hutchinson M	19652142	2009
45	CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5. ⁶¹ ²⁴	Goizet C...Stevanin G	19439420	2009
46	New pedigrees and novel mutation expand the phenotype of REEP1-associated hereditary spastic paraplegia (HSP). ⁶¹ ²⁴	Hewamadduma C...Shaw P	19034539	2009
47	Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations. ⁶¹ ²⁴	Orthmann-Murphy JL...Pareyson D	19056803	2009
48	Forceps minor region signal abnormality "ears of the lynx": an early MRI finding in spastic paraparesis with thin corpus callosum and mutations in the spatacsin gene (SPG11) on chromosome 15. ⁶¹ ²⁴	Riverol M...Masdeu JC	19040626	2009
49	SPG11 mutations are common in familial cases of complicated hereditary spastic paraplegia. ⁶¹ ²⁴	Paisan-Ruiz C...Singleton A	18337587	2008
50	Hereditary spastic paraplegia 3A associated with axonal neuropathy. ⁶¹ ²⁴	Ivanova N...De Jonghe P	17502470	2007

Sources

Genes for Hereditary Spastic Paraplegia

Genes related to Hereditary Spastic Paraplegia (11 elite genes):

(show top 50) (show all 159)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence	PubmedIds
1	SPAST	Spastin	Protein Coding	440.6	Pathogenic ⁶ DISEASES inferred ¹⁵ Novoseek inferred ⁵⁴ GeneCards inferred via : Publications Variants (show sections)	16009377 12676568 18701882 (more) 18202664 14732620 18410514 17895902 16026783 18190593 15823537 16684598 16682546 15242610 16476945 15891913 11039577 19619244 19494379 18613979 17868079 16476820 15667412 15210518 12552568 11843700 11087788 19875132 19141076 18644145 17916079 17598600 19714378 19620182 15716377 17531954 16009769 17598599 17425157 17560499 17389232 15637712 16815977 12490534 19039240 16832076 19453301 19423133 10980739 11377972
2	SPG7	SPG7 Matrix AAA Peptidase Subunit, Paraplegin	Protein Coding	438.22	Pathogenic/Likely pathogenic ⁶ DISEASES inferred ¹⁵ Novoseek inferred ⁵⁴ GeneCards inferred via : Publications Variants (show sections)	18200586 16534102 19841671 (more) 11377972 19289403 14985266 20186691 10480368 16357941 14623864 19625515 18563470 16239134
3	KIF5A	Kinesin Family Member 5A	Protein Coding	437.34	Pathogenic ⁶ DISEASES inferred ¹⁵ Novoseek inferred ⁵⁴ GeneCards inferred via : Publications Variants (show sections)	16476820 16489470
4	NIPA1	NIPA Magnesium Transporter 1	Protein Coding	436.67	Pathogenic ⁶ DISEASES inferred ¹⁵ Novoseek inferred ⁵⁴ GeneCards inferred via : Publications Variants (show sections)	16267846 19738379
5	CYP7B1	Cytochrome P450 Family 7 Subfamily B Member 1	Protein Coding	434.66	Pathogenic ⁶ DISEASES inferred ¹⁵ GeneCards inferred via : Publications Summaries Variants (show sections)
6	SPG11	SPG11 Vesicle Trafficking Associated, Spatacsin	Protein Coding	427.27	Pathogenic ⁶ DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
7	ZFYVE26	Zinc Finger FYVE-Type Containing 26	Protein Coding	425.4	Pathogenic ⁶ DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
8	GBA2	Glucosylceramidase Beta 2	Protein Coding	424.18	Pathogenic/Likely pathogenic ⁶ DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
9	KIF1A	Kinesin Family Member 1A	Protein Coding	424.1	Pathogenic/Likely pathogenic ⁶ DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
10	C19orf12	Chromosome 19 Open Reading Frame 12	Protein Coding	423.51	Pathogenic/Likely pathogenic ⁶ DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
11	KY	Kyphoscoliosis Peptidase	Protein Coding	415.76	Pathogenic ⁶ GeneCards inferred via : Publications Variants (show sections)
12	ALS2	Alsin Rho Guanine Nucleotide Exchange Factor ALS2	Protein Coding	34.06	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁴ GeneCards inferred via : Publications Variants (show sections)	16670179 14676054 12837691 (more) 12919135
13	ATL1	Atlastin GTPase 1	Protein Coding	29.5	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁴ GeneCards inferred via : Publications (show sections)	16533974 15477516 19423133 (more) 12939451 17030474 19633650 16009769 18644145 17427918 16815977 19494379 17380240 16476820
14	HSPD1	Heat Shock Protein Family D (Hsp60) Member 1	Protein Coding	28.54	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁴ GeneCards inferred via : Publications Variants (show sections)	19423133 18400758 18378094
15	SPART	Spartin	Protein Coding	27.97	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁴ GeneCards inferred via : Publications (show sections)	12676568 16781711 19765186 (more) 12134148 16945107 19620182
16	WASHC5	WASH Complex Subunit 5	Protein Coding	26.01	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Summaries (show sections)
17	REEP1	Receptor Accessory Protein 1	Protein Coding	25.91	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
18	ZFYVE27	Zinc Finger FYVE-Type Containing 27	Protein Coding	24.97	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Summaries (show sections)
19	AFG3L2	AFG3 Like Matrix AAA Peptidase Subunit 2	Protein Coding	24.92	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Summaries (show sections)
20	AP5Z1	Adaptor Related Protein Complex 5 Subunit Zeta 1	Protein Coding	24.63	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
21	DDHD1	DDHD Domain Containing 1	Protein Coding	24.43	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Summaries (show sections)
22	BSCL2	BSCL2 Lipid Droplet Biogenesis Associated, Seipin	Protein Coding	24.24	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
23	KIF1C	Kinesin Family Member 1C	Protein Coding	23.68	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
24	ERLIN2	ER Lipid Raft Associated 2	Protein Coding	23.43	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
25	AP4B1	Adaptor Related Protein Complex 4 Subunit Beta 1	Protein Coding	23.26	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
26	AP5B1	Adaptor Related Protein Complex 5 Subunit Beta 1	Protein Coding	23.25	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
27	PLP1	Proteolipid Protein 1	Protein Coding	23.23	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁴ GeneCards inferred via : Publications (show sections)	7643352 19955111
28	BICD2	BICD Cargo Adaptor 2	Protein Coding	23.16	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
29	SACS	Sacsin Molecular Chaperone	Protein Coding	23.13	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
30	AP4M1	Adaptor Related Protein Complex 4 Subunit Mu 1	Protein Coding	22.54	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
31	KATNB1	Katanin Regulatory Subunit B1	Protein Coding	22.45	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁴ GeneCards inferred via : Publications (show sections)	18202664
32	LONP1	Lon Peptidase 1, Mitochondrial	Protein Coding	21.98	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Summaries (show sections)
33	AMPD2	Adenosine Monophosphate Deaminase 2	Protein Coding	21.83	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
34	USP8	Ubiquitin Specific Peptidase 8	Protein Coding	21.45	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
35	CCT5	Chaperonin Containing TCP1 Subunit 5	Protein Coding	21	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
36	SLC16A2	Solute Carrier Family 16 Member 2	Protein Coding	20.94	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
37	MARS1	Methionyl-TRNA Synthetase 1	Protein Coding	20.55	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
38	WDR48	WD Repeat Domain 48	Protein Coding	19.83	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
39	GAD1	Glutamate Decarboxylase 1	Protein Coding	19.79	DISEASES inferred ¹⁵ GeneCards inferred via : Publications Variants (show sections)
40	DNAH8	Dynein Axonemal Heavy Chain 8	Protein Coding	16.89	Novoseek inferred ⁵⁴ GeneCards inferred via : Publications (show sections)	19619244 18410514
41	FA2H	Fatty Acid 2-Hydroxylase	Protein Coding	15.73	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
42	SPG21	SPG21 Abhydrolase Domain Containing, Maspardin	Protein Coding	15.48	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
43	DDHD2	DDHD Domain Containing 2	Protein Coding	15.43	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
44	RTN2	Reticulon 2	Protein Coding	15.09	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
45	CYP2U1	Cytochrome P450 Family 2 Subfamily U Member 1	Protein Coding	14.78	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
46	L1CAM	L1 Cell Adhesion Molecule	Protein Coding	14.71	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
47	PNPLA6	Patatin Like Phospholipase Domain Containing 6	Protein Coding	14.59	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
48	SLC33A1	Solute Carrier Family 33 Member 1	Protein Coding	14.44	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
49	B4GALNT1	Beta-1,4-N-Acetyl-Galactosaminyltransferase 1	Protein Coding	14.34	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
50	GJC2	Gap Junction Protein Gamma 2	Protein Coding	14.31	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)

Sources

Variations for Hereditary Spastic Paraplegia

ClinVar genetic disease variations for Hereditary Spastic Paraplegia:

⁶ (show top 50) (show all 94) ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎

#	Gene	Name	Type	Significance	ClinVarId	dbSNP ID	GRCh37 Pos	GRCh38 Pos
1	SPG11	NM_025137.4(SPG11):c.733_734del (p.Met245fs)	deletion	Pathogenic	1112	rs312262720	15:44949428-44949429	15:44657230-44657231
2	NIPA1	NM_144599.5(NIPA1):c.316G>A (p.Gly106Arg)	SNV	Pathogenic	2523	rs104894490	15:23060816-23060816	15:22812252-22812252
3	CYP7B1	NM_004820.5(CYP7B1):c.825T>A (p.Tyr275Ter)	SNV	Pathogenic	6105	rs121908613	8:65528273-65528273	8:64615716-64615716
4	KY	NM_178554.6(KY):c.51_52insTATCGACATGTGCTGTATCTATCGACAT (p.Val18fs)	insertion	Pathogenic	402246	rs1085307110	3:134369751-134369752	3:134650909-134650910
5	SPG7	NM_003119.4(SPG7):c.1053dup (p.Gly352fs)	duplication	Pathogenic	411675	rs760818649	16:89598370-89598371	16:89531962-89531963
6	SPAST	NM_014946.3(SPAST):c.1133T>A (p.Leu378Gln)	SNV	Pathogenic	424653	rs1553316816	2:32352051-32352051	2:32126982-32126982
7	CYP7B1	NM_004820.5(CYP7B1):c.914dup (p.Met305fs)	duplication	Pathogenic	424649	rs1554524697	8:65527725-65527726	8:64615168-64615169
8	KIF5A	NM_004984.4(KIF5A):c.610C>T (p.Arg204Trp)	SNV	Pathogenic	424651	rs1555177629	12:57961297-57961297	12:57567514-57567514
9	ZFYVE26	NM_015346.4(ZFYVE26):c.6296dup (p.Asn2100fs)	duplication	Pathogenic	424650	rs1555394376	14:68228992-68228993	14:67762275-67762276
10	SPG11	NM_025137.3(SPG11):c.(2244+1_2245-1)_(2620+1_2621-1)del	deletion	Pathogenic	424655
11	SPG11	NM_025137.4(SPG11):c.3711dup (p.Tyr1238fs)	duplication	Pathogenic	466523	rs750663981	15:44891009-44891010	15:44598811-44598812
12	SPG7	NM_003119.4(SPG7):c.771_772TG[1] (p.Val258fs)	short repeat	Pathogenic	504920	rs768136171	16:89595899-89595900	16:89529489-89529490
13	SPG7	NM_003119.4(SPG7):c.376G>C (p.Glu126Gln)	SNV	Pathogenic/Likely pathogenic	424654	rs912983346	16:89579445-89579445	16:89513037-89513037
14	SPG7	NM_003119.4(SPG7):c.1447C>T (p.Gln483Ter)	SNV	Pathogenic/Likely pathogenic	390378	rs562890289	16:89611178-89611178	16:89544770-89544770
15	SPG7	NM_003119.3(SPG7):c.1454_1462delGGCGGGAGA (p.Arg485_Glu487del)	deletion	Pathogenic/Likely pathogenic	411680	rs768823392	16:89613065-89613073	16:89546657-89546665
16	C19orf12	NM_001256047.1(C19orf12):c.124G>A (p.Gly42Arg)	SNV	Pathogenic/Likely pathogenic	183298	rs200133991	19:30199197-30199197	19:29708290-29708290
17	KIF1A	NM_004321.7(KIF1A):c.206C>T (p.Ser69Leu)	SNV	Pathogenic/Likely pathogenic	188057	rs786200949	2:241727625-241727625	2:240788208-240788208
18	GBA2	NM_020944.3(GBA2):c.1888C>T (p.Arg630Trp)	SNV	Pathogenic/Likely pathogenic	41485	rs398123012	9:35738808-35738808	9:35738811-35738811
19	GBA2	NM_020944.3(GBA2):c.2618G>A (p.Arg873His)	SNV	Pathogenic/Likely pathogenic	41490	rs398123015	9:35737332-35737332	9:35737335-35737335
20	DDHD2	NM_015214.2(DDHD2):c.1249_1891del	deletion	Likely pathogenic	183317
21	REEP1	NM_001164731.2(REEP1):c.25-18176G>C	SNV	Likely pathogenic	424660	rs1266102026	2:86509340-86509340	2:86282217-86282217
22	KIF5A	NM_004984.4(KIF5A):c.833C>T (p.Pro278Leu)	SNV	Likely pathogenic	424658	rs1555177824	12:57963052-57963052	12:57569269-57569269
23	KIF5A	NM_004984.4(KIF5A):c.868G>C (p.Asp290His)	SNV	Likely pathogenic	424659	rs1555177831	12:57963087-57963087	12:57569304-57569304
24	ERLIN2	NM_007175.8(ERLIN2):c.899A>T (p.Asp300Val)	SNV	Likely pathogenic	424656	rs763958615	8:37611512-37611512	8:37753994-37753994
25	KIF1C	NM_006612.6(KIF1C):c.1111G>A (p.Ala371Thr)	SNV	Conflicting interpretations of pathogenicity	424675	rs142056835	17:4908241-4908241	17:5004946-5004946
26	KIF1C	NM_006612.6(KIF1C):c.2299G>A (p.Gly767Arg)	SNV	Conflicting interpretations of pathogenicity	424674	rs118037269	17:4925675-4925675	17:5022380-5022380
27	SACS	NM_014363.6(SACS):c.5629C>T (p.Arg1877Ter)	SNV	Conflicting interpretations of pathogenicity	371545	rs761089024	13:23912386-23912386	13:23338247-23338247
28	KIF1A	NM_004321.7(KIF1A):c.31C>T (p.Arg11Trp)	SNV	Conflicting interpretations of pathogenicity	424652	rs548204329	2:241737139-241737139	2:240797722-240797722
29	SETX	NM_015046.7(SETX):c.3826C>G (p.Gln1276Glu)	SNV	Conflicting interpretations of pathogenicity	424692	rs148604312	9:135203159-135203159	9:132327772-132327772
30	SETX	NM_015046.7(SETX):c.3229G>A (p.Asp1077Asn)	SNV	Conflicting interpretations of pathogenicity	424687	rs145097270	9:135203756-135203756	9:132328369-132328369
31	MAG	NM_002361.4(MAG):c.452C>T (p.Ala151Val)	SNV	Conflicting interpretations of pathogenicity	424686	rs144553163	19:35790493-35790493	19:35299590-35299590
32	SPG7	NM_003119.4(SPG7):c.1529C>T (p.Ala510Val)	SNV	Conflicting interpretations of pathogenicity	42016	rs61755320	16:89613145-89613145	16:89546737-89546737
33	SPG11	NM_025137.4(SPG11):c.3818A>G (p.Lys1273Arg)	SNV	Conflicting interpretations of pathogenicity	130365	rs76389165	15:44890903-44890903	15:44598705-44598705
34	BICD2	NM_001003800.2(BICD2):c.269A>G (p.Lys90Arg)	SNV	Conflicting interpretations of pathogenicity	235235	rs61754130	9:95491490-95491490	9:92729208-92729208
35	SACS	NM_014363.6(SACS):c.1373C>T (p.Thr458Ile)	SNV	Conflicting interpretations of pathogenicity	282385	rs61729954	13:23929378-23929378	13:23355239-23355239
36	ALS2	NM_020919.4(ALS2):c.3206G>A (p.Gly1069Glu)	SNV	Conflicting interpretations of pathogenicity	333592	rs200706696	2:202591249-202591249	2:201726526-201726526
37	NIPA1	NM_144599.5(NIPA1):c.24_26GGC[10] (p.Ala15_Ala16dup)	short repeat	Conflicting interpretations of pathogenicity	193496	rs531550505	15:23086364-23086365	15:22786677-22786678
38	SACS	NM_014363.6(SACS):c.13717A>C (p.Asn4573His)	SNV	Conflicting interpretations of pathogenicity	193707	rs34382952	13:23904298-23904298	13:23330159-23330159
39	KIF1C	NM_006612.6(KIF1C):c.2734C>T (p.Arg912Trp)	SNV	Conflicting interpretations of pathogenicity	209167	rs202232792	17:4926868-4926868	17:5023573-5023573
40	CYP7B1	NM_004820.5(CYP7B1):c.1456C>T (p.Arg486Cys)	SNV	Conflicting interpretations of pathogenicity	6107	rs116171274	8:65509264-65509264	8:64596707-64596707
41	KIF5A	NM_004984.4(KIF5A):c.839G>A (p.Arg280His)	SNV	Conflicting interpretations of pathogenicity	37130	rs387907288	12:57963058-57963058	12:57569275-57569275
42	SPG7	NM_003119.4(SPG7):c.1933T>A (p.Ser645Thr)	SNV	Uncertain significance	215194	rs2099104	16:89619540-89619540	16:89553132-89553132
43	SACS	NM_014363.6(SACS):c.1640C>T (p.Pro547Leu)	SNV	Uncertain significance	311560	rs140507581	13:23929111-23929111	13:23354972-23354972
44	WDR48	NM_020839.4(WDR48):c.280T>G (p.Ser94Ala)	SNV	Uncertain significance	424665	rs148407227	3:39108050-39108050	3:39066559-39066559
45	CCT5	NM_012073.5(CCT5):c.487G>A (p.Glu163Lys)	SNV	Uncertain significance	424664	rs552008894	5:10256222-10256222	5:10256110-10256110
46	ARSI	NM_001012301.4(ARSI):c.1456C>T (p.Arg486Cys)	SNV	Uncertain significance	424689	rs139095592	5:149677031-149677031	5:150297468-150297468
47	ARSI	NM_001012301.4(ARSI):c.1114G>A (p.Asp372Asn)	SNV	Uncertain significance	424672	rs150211860	5:149677373-149677373	5:150297810-150297810
48	AP4M1	NM_004722.4(AP4M1):c.607-2A>G	SNV	Uncertain significance	424662	rs755533568	7:99702495-99702495	7:100104872-100104872
49	AP5Z1	NM_014855.3(AP5Z1):c.272G>A (p.Arg91Gln)	SNV	Uncertain significance	424695	rs750211507	7:4821291-4821291	7:4781660-4781660
50	AP5Z1	NM_014855.3(AP5Z1):c.838A>C (p.Thr280Pro)	SNV	Uncertain significance	424671	rs554060393	7:4824586-4824586	7:4784955-4784955

Copy number variations for Hereditary Spastic Paraplegia from CNVD:

⁷

#	CNVD ID	Chromosome	Start	End	Type	Gene Symbol	CNVD Disease
1	144964	2	32142183	32236210	Deletion	SPAST	hereditary spastic paraplegia

Sources

Expression for Hereditary Spastic Paraplegia

Search GEO for disease gene expression data for Hereditary Spastic Paraplegia.

Sources

Pathways for Hereditary Spastic Paraplegia

Pathways related to Hereditary Spastic Paraplegia according to KEGG:

³⁶

#	Name	Kegg Source Accession
1	Endocytosis	hsa04144
2	Lysosome	hsa04142

Pathways related to Hereditary Spastic Paraplegia according to GeneCards Suite gene sharing:

#	Super pathways	Score	Top Affiliating Genes
1	Endocytosis ³⁶	11.32	ZFYVE27 WASHC5 SPART KIF5A

Sources

GO Terms for Hereditary Spastic Paraplegia

Cellular components related to Hereditary Spastic Paraplegia according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	endoplasmic reticulum membrane	GO:0005789	9.88	ZFYVE27 SPAST REEP1 GBA2 CYP7B1 ATL1
2	endoplasmic reticulum	GO:0005783	9.86	ZFYVE27 WASHC5 SPAST REEP1 GBA2 CYP7B1
3	axon	GO:0030424	9.72	ZFYVE27 SPG11 KIF1A ATL1 ALS2
4	early endosome	GO:0005769	9.67	WASHC5 NIPA1 HSPD1 ALS2
5	m-AAA complex	GO:0005745	9.16	SPG7 AFG3L2
6	endoplasmic reticulum tubular network	GO:0071782	9.13	ZFYVE27 REEP1 ATL1
7	axon cytoplasm	GO:1904115	8.92	SPG7 SPAST KIF5A KIF1A

Biological processes related to Hereditary Spastic Paraplegia according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	endosomal transport	GO:0016197	9.43	WASHC5 AP5Z1 ALS2
2	mitochondrial calcium ion transmembrane transport	GO:0006851	9.4	SPG7 AFG3L2
3	synaptic vesicle transport	GO:0048489	9.37	SPG11 KIF5A
4	mitochondrial calcium ion homeostasis	GO:0051560	9.32	C19orf12 AFG3L2
5	retrograde neuronal dense core vesicle transport	GO:1990049	9.16	KIF5A KIF1A
6	anterograde axonal transport	GO:0008089	9.13	SPG7 SPAST KIF1A
7	axonogenesis	GO:0007409	8.92	SPAST ATL1 ALS2 AFG3L2

Molecular functions related to Hereditary Spastic Paraplegia according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	unfolded protein binding	GO:0051082	9.33	SPG7 HSPD1 AFG3L2
2	microtubule binding	GO:0008017	9.26	SPAST REEP1 KIF5A KIF1A
3	ATPase activity	GO:0016887	8.92	SPAST KIF5A KIF1A HSPD1

Sources

Sources for Hereditary Spastic Paraplegia

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FMA

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ Genetics Home Reference

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HMDB

³¹ HPO

³² ICD10

³³ ICD10 via Orphanet

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ KEGG

³⁷ LifeMap

³⁸ LncRNADisease

³⁹ LOVD

⁴⁰ MalaCards

⁴¹ MedGen

⁴² MedlinePlus

⁴³ MeSH

⁴⁴ MESH via Orphanet

⁴⁵ MGI

⁴⁶ miR2Disease

⁴⁷ NCBI Bookshelf

⁴⁸ NCI

⁴⁹ NCIt

⁵⁰ NDF-RT

⁵¹ NIH Clinical Center

⁵² NIH Rare Diseases

⁵³ NINDS

⁵⁴ Novoseek

⁵⁵ Novus Biologicals

⁵⁶ OMIM

⁵⁷ OMIM via Orphanet

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubMed

⁶² PubMed Health

⁶³ QIAGEN

⁶⁴ R&D Systems

⁶⁵ Reactome

⁶⁶ Sino Biological

⁶⁷ SNOMED-CT

⁶⁸ SNOMED-CT via HPO

⁶⁹ TGDB

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ Wikipedia

Hereditary Spastic Paraplegia (FSP)

Aliases & Classifications for Hereditary Spastic Paraplegia

MalaCards integrated aliases for Hereditary Spastic Paraplegia:

Characteristics:

Orphanet epidemiological data:

Classifications:

External Ids:

Summaries for Hereditary Spastic Paraplegia

Related Diseases for Hereditary Spastic Paraplegia

Diseases in the Spastic Paraplegia 3a family:

Diseases related to Hereditary Spastic Paraplegia via text searches within MalaCards or GeneCards Suite gene sharing:

Graphical network of the top 20 diseases related to Hereditary Spastic Paraplegia:

Symptoms & Phenotypes for Hereditary Spastic Paraplegia

Human phenotypes related to Hereditary Spastic Paraplegia:

UMLS symptoms related to Hereditary Spastic Paraplegia:

MGI Mouse Phenotypes related to Hereditary Spastic Paraplegia:

Drugs & Therapeutics for Hereditary Spastic Paraplegia

Drugs for Hereditary Spastic Paraplegia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

Interventional clinical trials:

Cochrane evidence based reviews: spastic paraplegia, hereditary

Genetic Tests for Hereditary Spastic Paraplegia

Genetic tests related to Hereditary Spastic Paraplegia:

Anatomical Context for Hereditary Spastic Paraplegia

MalaCards organs/tissues related to Hereditary Spastic Paraplegia:

Publications for Hereditary Spastic Paraplegia

Articles related to Hereditary Spastic Paraplegia:

Genes for Hereditary Spastic Paraplegia

Genes related to Hereditary Spastic Paraplegia (11 elite genes):

Variations for Hereditary Spastic Paraplegia

ClinVar genetic disease variations for Hereditary Spastic Paraplegia:

Copy number variations for Hereditary Spastic Paraplegia from CNVD:

Expression for Hereditary Spastic Paraplegia

Pathways for Hereditary Spastic Paraplegia

Pathways related to Hereditary Spastic Paraplegia according to KEGG:

Pathways related to Hereditary Spastic Paraplegia according to GeneCards Suite gene sharing:

GO Terms for Hereditary Spastic Paraplegia

Cellular components related to Hereditary Spastic Paraplegia according to GeneCards Suite gene sharing:

Biological processes related to Hereditary Spastic Paraplegia according to GeneCards Suite gene sharing:

Molecular functions related to Hereditary Spastic Paraplegia according to GeneCards Suite gene sharing:

Sources for Hereditary Spastic Paraplegia